Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Abbott 48999
2. Abbott-48999
3. Abbott48999
4. Cefotiam Hydrochloride
5. Ceradolan
6. Cgp 14221 E
7. Cgp-14221-e
8. Cgp14221e
9. Haloapor
10. Halospor
11. Hydrochloride, Cefotiam
12. Sce 963
13. Sce-963
14. Sce963
1. 61622-34-2
2. Cefotiamum
3. Cefotiamum [inn-latin]
4. Ceradon
5. Aspil
6. Ctm
7. Cefotiam (inn)
8. J01dc07
9. Chebi:355510
10. 91w6z2n718
11. Cefotiam [inn]
12. Cefotiam [inn:ban]
13. (6r,7r)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
14. (6r,7r)-7-[2-(2-amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1h-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
15. Cgp 14221e
16. 66309-69-1
17. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl]thio]methyl]-8-oxo-, (6r,7r)-
18. Aspil (tn)
19. Sr-01000841230
20. Unii-91w6z2n718
21. Cefotiam,(s)
22. (6r,7r)-7-(2-(2-aminothiazol-4-yl)acetamido)-3-((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
23. Cefotiam [jan]
24. Cefotiam [mi]
25. Prestwick0_000482
26. Prestwick1_000482
27. Prestwick2_000482
28. Prestwick3_000482
29. Cefotiam [who-dd]
30. Chembl1296
31. Bspbio_000343
32. Schembl149538
33. Spbio_002264
34. Bpbio1_000379
35. Dtxsid6022763
36. Schembl11224134
37. Hy-b0734
38. Zinc3830445
39. Bdbm50485561
40. Db00229
41. Ncgc00179594-01
42. (6r,7r)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
43. (6r,7r)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl}thio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
44. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-trans)-
45. 7beta-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic Acid
46. Ab00514684
47. Cs-0009630
48. C21544
49. D07648
50. 622c342
51. J-700162
52. Q3009984
53. Sr-01000841230-2
54. Brd-k02275692-003-03-4
55. (6r,7r)-7-[2-(2-amino-1,3-thiazol-4-yl)acetamido]-3-[({1-[2-(dimethylamino)ethyl]-1h-1,2,3,4-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
56. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl]thio]methyl]-8-oxo-,(6r,7r)-
57. 7beta-(2-imino-4-thiazolin-4-yl)acetamido-3-{1-[2-(n,n-dimethylamino)ethyl]-1h-tetrazol-5-yl}thiomethyl-3-cephem-4-carboxylic Acid
58. 7beta-[ 2-(2-aminothiazol-4-yl) Acetamido]-3-[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]thiomethyl-3-cephem-4-carboxylic Acid
| Molecular Weight | 525.6 g/mol |
|---|---|
| Molecular Formula | C18H23N9O4S3 |
| XLogP3 | -2.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 10 |
| Exact Mass | 525.10351377 g/mol |
| Monoisotopic Mass | 525.10351377 g/mol |
| Topological Polar Surface Area | 251 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 848 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For treatment of severe infections caused by susceptible bacteria.
Cefotiam is a third generation beta-lactam cephalosporin antibiotic that works by inhibiting bacterial cell wall biosynthesis. It is a broad spectrum antibiotic that is effective against Gram positive and Gram negative bacteria.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DC - Second-generation cephalosporins
J01DC07 - Cefotiam
Absorption
Rapidly absorbed following intramuscular injection. Bioavailability is 60% following intramuscular injection.
Approximately 1 hour.
The bactericidal activity of cefotiam results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Cefotiam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefotiam, including repackagers and relabelers. The FDA regulates Cefotiam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefotiam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefotiam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefotiam supplier is an individual or a company that provides Cefotiam active pharmaceutical ingredient (API) or Cefotiam finished formulations upon request. The Cefotiam suppliers may include Cefotiam API manufacturers, exporters, distributors and traders.
click here to find a list of Cefotiam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefotiam DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefotiam active pharmaceutical ingredient (API) in detail. Different forms of Cefotiam DMFs exist exist since differing nations have different regulations, such as Cefotiam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefotiam DMF submitted to regulatory agencies in the US is known as a USDMF. Cefotiam USDMF includes data on Cefotiam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefotiam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefotiam suppliers with USDMF on PharmaCompass.
Cefotiam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefotiam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefotiam GMP manufacturer or Cefotiam GMP API supplier for your needs.
A Cefotiam CoA (Certificate of Analysis) is a formal document that attests to Cefotiam's compliance with Cefotiam specifications and serves as a tool for batch-level quality control.
Cefotiam CoA mostly includes findings from lab analyses of a specific batch. For each Cefotiam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefotiam may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefotiam EP), Cefotiam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefotiam USP).
LOOKING FOR A SUPPLIER?
